Dashboard
Discussions
Watchlists
Collections
More
Events
Tools
SIGN UP
SIGN IN
bullish
China Healthcare Weekly (July.16)
The article mainly analyzed China's plan to accelerate the construction of plasma stations, promising outlook of medical IT industry & immunonutrition products (e.g. probiotics) and the market review.
Thematic (Sector/Industry)
220 Views
18 Jul 2021 09:05
SUMMARY
(Sign Up to Access)
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
Unlimited Research Summaries
Personalised Alerts
Custom Watchlists
Company Analytics & News
Events & Webinars
Trusted by:
SMARTKARMA PREVIEW PASS
Sign Up with LinkedIn
or
First Name
Last name
Email
Sign Up with Email
By signing up, you agree to our
Terms of Use
and
Privacy Policy
.
Trusted by:
Already have an account?
Sign In Now
Full Insight
(Paid Plans Only)
Discussions
(Paid Plans Only)
Top Quartile
Xinyao (Criss) Wang
HK/China Healthcare Analyst (ex-Fosun Pharma)
China
Health Care
Equity Bottom-Up
Thematic (Sector/Industry)
View Full Profile
Insight Stream
China Healthcare Weekly (Aug.6)
08 Aug 2021
China Healthcare Weekly (July.30)
01 Aug 2021
China Healthcare Weekly (July.23)
25 Jul 2021
China Healthcare Weekly (July.16)
18 Jul 2021
Beijing Wantai Biological (603392.CH) - How to Support Its High Valuation?
15 Jul 2021
Pre-IPO MicroPort MedBot - The Core Products, the Business Model and the Concerns
13 Jul 2021
China Healthcare Weekly (July.9)
11 Jul 2021
Top
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.24.1
x